Pellerin David, Iruzubieta Pablo, Xu Isaac R L, Danzi Matt C, Cortese Andrea, Synofzik Matthis, Houlden Henry, Zuchner Stephan, Brais Bernard
Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.
Curr Neurol Neurosci Rep. 2025 Jan 16;25(1):16. doi: 10.1007/s11910-024-01400-8.
Autosomal dominant cerebellar ataxias, also known as spinocerebellar ataxias (SCAs), are genetically and clinically diverse neurodegenerative disorders characterized by progressive cerebellar dysfunction. Despite advances in sequencing technologies, a large proportion of patients with SCA still lack a definitive genetic diagnosis. The advent of advanced bioinformatic tools and emerging genomics technologies, such as long-read sequencing, offers an unparalleled opportunity to close the diagnostic gap for hereditary ataxias. This article reviews the recently identified repeat expansion SCAs and describes their molecular basis, epidemiology, and clinical features.
Leveraging advanced bioinformatic tools and long-read sequencing, recent studies have identified novel pathogenic short tandem repeat expansions in FGF14, ZFHX3, and THAP11, associated with SCA27B, SCA4, and SCA51, respectively. SCA27B, caused by an intronic (GAA)•(TTC) repeat expansion, has emerged as one of the most common forms of adult-onset hereditary ataxias, especially in European populations. The coding GGC repeat expansion in ZFHX3 causing SCA4 was identified more than 25 years after the disorder's initial clinical description and appears to be a rare cause of ataxia outside northern Europe. SCA51, caused by a coding CAG repeat expansion, is overall rare and has been described in a small number of patients. The recent identification of three novel pathogenic repeat expansions underscores the importance of this class of genomic variation in the pathogenesis of SCAs. Progress in sequencing technologies holds promise for closing the diagnostic gap in SCAs and guiding the development of therapeutic strategies for ataxia.
常染色体显性遗传性小脑共济失调,也称为脊髓小脑共济失调(SCA),是一类具有遗传和临床异质性的神经退行性疾病,其特征为进行性小脑功能障碍。尽管测序技术取得了进展,但仍有很大一部分SCA患者缺乏明确的基因诊断。先进的生物信息学工具和新兴的基因组技术(如长读长测序)的出现,为缩小遗传性共济失调的诊断差距提供了前所未有的机会。本文综述了最近发现的重复序列扩张型SCA,并描述了它们的分子基础、流行病学和临床特征。
利用先进的生物信息学工具和长读长测序技术,最近的研究在FGF14、ZFHX3和THAP11中分别发现了与SCA27B、SCA4和SCA51相关的新型致病性短串联重复序列扩张。由内含子(GAA)•(TTC)重复序列扩张引起的SCA27B已成为成人发病的遗传性共济失调最常见的形式之一,尤其是在欧洲人群中。导致SCA4的ZFHX3编码区GGC重复序列扩张在该疾病最初临床描述25年多后才被发现,似乎是北欧以外地区共济失调的罕见病因。由编码区CAG重复序列扩张引起的SCA51总体上较为罕见,仅在少数患者中被描述。最近发现的三种新型致病性重复序列扩张突出了这类基因组变异在SCA发病机制中的重要性。测序技术的进展有望缩小SCA的诊断差距,并指导共济失调治疗策略的开发。